333 related articles for article (PubMed ID: 17704413)
1. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
[TBL] [Abstract][Full Text] [Related]
2. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
3. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
[TBL] [Abstract][Full Text] [Related]
4. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
5. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
6. Cardiac function in Wilms' tumor survivors.
Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I
J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343
[TBL] [Abstract][Full Text] [Related]
7. Subclinical late cardiac toxicity in childhood cancer survivors: impact on self-reported health.
Cox CL; Rai SN; Rosenthal D; Phipps S; Hudson MM
Cancer; 2008 Apr; 112(8):1835-44. PubMed ID: 18311782
[TBL] [Abstract][Full Text] [Related]
8. Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.
Elbl L; Hrstkova H; Tomaskova I; Blazek B; Michalek J
Eur J Pediatr; 2005 Nov; 164(11):678-84. PubMed ID: 16044276
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.
Dietz AC; Sivanandam S; Konety S; Kaufman CL; Gage RM; Kelly AS; Neglia JP; Mulrooney DA
J Cancer Surviv; 2014 Jun; 8(2):183-9. PubMed ID: 24317971
[TBL] [Abstract][Full Text] [Related]
10. Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?
Pourier MS; Mavinkurve-Groothuis AM; Loonen J; Bökkerink JP; Roeleveld N; Beer G; Bellersen L; Kapusta L
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27654133
[TBL] [Abstract][Full Text] [Related]
11. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines.
Pourier MS; Kapusta L; van Gennip A; Bökkerink JP; Loonen J; Bellersen L; Mavinkurve-Groothuis AM
Clin Chim Acta; 2015 Feb; 441():29-32. PubMed ID: 25512165
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.
Andolina JR; Dilley K
J Pediatr Hematol Oncol; 2010 Jul; 32(5):411-5. PubMed ID: 20495481
[TBL] [Abstract][Full Text] [Related]
14. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
[TBL] [Abstract][Full Text] [Related]
15. Are cardiac magnetic resonance imaging and radionuclide ventriculography good options against echocardiography for evaluation of anthracycline induced chronic cardiotoxicity in childhood cancer survivors?
Basar EZ; Corapcioglu F; Babaoglu K; Anik Y; Gorur Daglioz G; Dedeoglu R
Pediatr Hematol Oncol; 2014 Apr; 31(3):237-52. PubMed ID: 24499452
[TBL] [Abstract][Full Text] [Related]
16. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
17. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.
Christiansen JR; Kanellopoulos A; Lund MB; Massey R; Dalen H; Kiserud CE; Ruud E; Aakhus S
Pediatr Blood Cancer; 2015 Aug; 62(8):1437-43. PubMed ID: 25832752
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy.
Ylänen K; Eerola A; Vettenranta K; Poutanen T
Am J Cardiol; 2014 Jun; 113(11):1886-92. PubMed ID: 24837269
[TBL] [Abstract][Full Text] [Related]
20. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study.
van der Pal HJ; van Dijk IW; Geskus RB; Kok WE; Koolen M; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC; van Dalen EC
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):213-22. PubMed ID: 25442333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
